South Africa Women’s Health Market Size & Outlook
South Africa women’s health market, 2018-2030 (US$M)
Related Markets
South Africa women’s health market highlights
- The South Africa women’s health market generated a revenue of USD 202.6 million in 2023 and is expected to reach USD 323.6 million by 2030.
- The South Africa market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2023.
- Endometriosis & Uterine Fibroids is the most lucrative application segment registering the fastest growth during the forecast period.
Women’s health market data book summary
| Market revenue in 2023 | USD 202.6 million |
| Market revenue in 2030 | USD 323.6 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Endometriosis & Uterine Fibroids |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.5% of the global women’s health market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia women’s health market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 323.6 million by 2030.
Contraceptives was the largest segment with a revenue share of 36.97% in 2023. Horizon Databook has segmented the South Africa women’s health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
In Africa, approximately 22.6% of women of reproductive age do not have access to advanced contraceptives. Hence, women's health products have not yet penetrated South Africa, but the market is expected to grow at a substantial rate over the forecast period.
Some of the key factors anticipated to result in market growth are high unmet medical needs, increasing awareness about women's health issues, and the growing population of elderly women. Anemia affects approximately one-third of women in South Africa.
Such a high prevalence of anemia is increasing the risk of developing severe women’s health issues in the country. Moreover, according to the International Osteoporosis Foundation, about 1.4 million women aged above 50 are suffering from osteoporosis.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women’s Health Market Scope
Women’s Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa women’s health market size, by application, 2018-2030 (US$M)
South Africa Women’s Health Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
